September 20, 2022

Earl and I begin this journey with some hope that we can find a way to control the effects of his NASH, which is a liver disease which we believe was caused by a childhood case of hepatitis. 

This is an acronym for non alcoholic steatotic hepatitis which is a chronic inflammation of the liver. He is at stage 4. Next would be liver failure. 

We entered the world of clinical trial with a visit to the Sierra Clinic.

From this visit we were sent to various diagnostic appointments to assess his acceptance into the study. first was an ultrasound then a liver biopsy on October 18.  

Earl passed all the criteria and was accepted into the program in November 2022.

 

Comments

Popular posts from this blog

Nash Study March 2023 clinic visit